12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
Show full item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Coming Soon


MLibrary logo